FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Issue Open | October 31, 2022 |
Issue Close | November 10, 2022 |
Issue Size (Shares) | 7.27 Crores |
Issue Size (Amount) | ₹399.80 Crores |
Issue Price | ₹55 per Share |
Listing At | BSE, NSE |
September 13, 2024 3:23:00 AM
Developers say it will take a while for interest rate cuts to have a tangible effect on demand, and in the meantime, they are getting creative to land tenants.
Published by : BisnowSeptember 15, 2024 2:30:00 PM
The unintended consequences of legislation are often as important as the original purpose. Two bills scheduled to be considered next month by the U.S. Senate�s Committee on Health, Education, Labor, ...
Published by : The GazetteSeptember 11, 2024 12:30:00 AM
The first notable agency action in 2024 is the FTC�s Second Request in Novo Holding�s proposed $16.5 billion acquisition of Catalent, a life sciences contract manufacturer. 1 The agency�s interest in ...
Published by : JD SupraSeptember 10, 2024 1:18:00 PM
New York also has much less subleased space on the market than other cities, indicating that life sciences firms didn't lease too much space when the market was growing that they ultimately had to get ...
Published by : Crain's New YorkSeptember 16, 2024 3:30:00 AM
This update is part of our EU AI Act Series. Learn more about the EU AI Act here. Life sciences and digital health companies face obligations under the AI Act that vary depending on how they use AI � ...
Published by : JD SupraRead Suven Life Sciences Rights Issue 2022 current news. Find Suven Life Sciences Rights Issue 2022 subscription news, Rights Issue analysis, broker reviews, allotment news, and listing date. Get the Suven Life Sciences Limited Rights Issue grey market premium and Suven Life Sciences Rights Issue 2022 expected listing price.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|